We have updated our privacy policy. If you have any question, contact us at privacy@scicrunch.org. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Science (New York, N.Y.) | Nov 28, 1997

A lymphocyte subpopulation, the Valpha14 natural killer T (NKT) cells, expresses both NK1.1 and a single invariant T cell receptor encoded by the Valpha14 and Jalpha281 gene segments. Mice with a deletion of the Jalpha281 gene segment were found to exclusively lack this subpopulation. The Valpha14 NKT cell-deficient mice could no longer mediate the interleukin-12 (IL-12)-induced rejection of tumors. Although the antitumor effect of IL-12 was thought to be mediated through natural killer cells and T cells, Valpha14 NKT cells were found to be an essential target of IL-12, and they mediated their cytotoxicity by an NK-like effector mechanism after activation with IL-12.

Pubmed ID: 9374462 RIS Download

Mesh terms: Animals | Anti-Bacterial Agents | Cytotoxicity, Immunologic | Gene Deletion | Gene Targeting | Genes, RAG-1 | Genes, T-Cell Receptor alpha | Interferon-gamma | Interleukin-12 | Killer Cells, Natural | Macrolides | Melanoma, Experimental | Mice | Mice, Inbred C57BL | Mice, Transgenic | Neoplasms, Experimental | Poly I-C | Proton-Translocating ATPases | Receptors, Antigen, T-Cell, alpha-beta | T-Lymphocyte Subsets